TAYSHA GENE THERAPIES AND CATALENT EXPAND STRATEGIC PARTNERSHIP TO INCLUDE FUTURE COMMERCIAL MANUFACTURING SUPPORT OF TSHA-102 GENE THERAPY FOR RETT SYNDROME

Reuters · 3d ago

Please log in to view news